Since the COVID-19 outbreak in China in the end of 2019, IDA has been actively working on the sourcing of Personal Protective Equipment (PPE) products for COVID-19 response, anticipating upcoming global healthcare challenges, especially in low-and middle-income countries. As there is no official treatment available yet for COVID-19, our current focus is on ensuring people, especially healthcare workers, are protected while doing their work. We are also looking at the supply of diagnostic tests and other COVID-19-related items.
We are currently supplying large quantities of PPE to over 30 different customers worldwide. To rapidly scale up in the supply of PPE, IDA set up an emergency QA approval process which incorporates IDA's quality guidelines (see Quality). This has allowed us to efficiently and effectively approve PPE products from a broad range of suppliers, all well documented in IDA’s Quality Management System. Through our China office, IDA is up to date on all market developments, and we have been able to find solutions for export limitations, a typical COVID-19 challenge for PPE that is expected to continue at least the coming months.
Below is a selection of items currently in our COVID-19 portfolio. Please note we are constantly updating our product lists and leaflets will be added to this page as we are expanding our portfolio.
- Coverall (protective suit)
- Examination gloves (latex / nitrile)
- Face shield
- Head cap
- Isolation gown
- Medical face mask (Type I / Type II / Type IIR)
- Respirator KN95 (mask)
- Shoe covers
Covid-19 related items
- Biohazard bags
- Hand disinfectants
- Oxygen concentrator
- Thermometer infrared
Ordering COVID-19 items from IDA
As a qualified IDA customer, you can order PPE from us as well as other COVID-19 related items such as diagnostic tests. You can contact your sales representative for the latest version. To become a customer you can register via the Customer Registration page.
This page will be updated regularly with the latest information available. Please also see our COVID-19 FAQ page for the latest relevant updates.